Statement Of Changes In Equity [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166306

Concept	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	54,805 EUR	476,000 EUR	—	—	48,056 EUR	—	3,827 EUR	—	103,693 EUR	—	2,391 EUR	129,000 EUR	—	—	—	—	43,226 EUR	129,000 EUR	3,827 EUR	—	—	476,000 EUR	103,693 EUR	—	1,814 EUR	—	59,059 EUR	—	- EUR	493,000 EUR	23,982 EUR	10,188 EUR	36,081 EUR	1,329 EUR	89,000 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	—	—	—	—	—	—	—	—	—	11,579 EUR	—	—	7,145 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Other comprehensive income	—	—	—	—	—	—	—	—	—	—	—	—	- EUR	—	—	- EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	—	—	- EUR	- EUR	—	- EUR	—	—	—	- EUR	—	—	11,579 EUR	11,579 EUR	—	7,145 EUR	—	—	—	7,145 EUR	—	—	—	- EUR	—	- EUR	—	- EUR	—	—	—	—	—	—	—
Issue of equity	—	—	—	—	—	—	—	—	—	—	—	—	—	—	3,725 EUR	60,668 EUR	—	—	—	- EUR	—	—	—	- EUR	—	30,000 EUR	—	64,363 EUR	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	- EUR	- EUR	—	- EUR	—	576,000 EUR	—	- EUR	—	—	576,000 EUR	- EUR	- EUR	485,000 EUR	—	—	—	- EUR	485,000 EUR	—	—	- EUR	—	- EUR	—	- EUR	—	—	—	—	—	—	—